Brief vs. Extended Buprenorphine Detoxification in a Community Treatment Program: Engagement and Short-Term Outcomes

REFERENCES

• Substance Abuse and Mental Health Services Administration Office of Applied Studies. Treatment Episode Data Set (TEDS) Highlights—2006. National Admissions to Substance Abuse Treatment Services, DASIS Series: S-40, DHHS Publication No. (SMA) 08-4313, Rockville, MD, Table 4
   Google Scholar
• Becker A, Strain E, Bigelow G, Stitzer M, Johnson R. Gradual dose taper following chronic buprenorphine. The American Journal on Addictions 2001; 10: 111–121
   PubMed Web of Science ®Google Scholar
• Greenwald M, Schuh K, Stine S. Transferring Methadone-maintained outpatients to the buprenorphine sublingual tablet: A preliminary study. The American Journal on Addictions 2003; 12: 365–374
   PubMed Web of Science ®Google Scholar
• Bell J, Byron G, Gibson A, Morris A. A pilot study of buprenorphine-naloxone combination tablet (Suboxone®) in treatment of opioid dependence. Drug and Alcohol Review 2004; 23: 311–317
   PubMed Web of Science ®Google Scholar
• Collins E, Kleber H, Whittington R, Heitler N. Anesthesia-assisted vs. buprenorphine-or clonidine-assisted heroin detoxification and naltrexone induction:. The Journal of the American Medical Association 2005; 294: 903–913
   PubMed Web of Science ®Google Scholar
• Gandhi D, Jaffe J, McNary S, Kavanagh G, Hayes M, Currens M. Short-term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users. Addiction 2003; 98: 453–462
   PubMed Web of Science ®Google Scholar
• Amass L, Bickel W K, Higgins S, Hughes J. A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification. Journal of Addictive Disease 2005; 13: 33–45
   Google Scholar
• Diamant K, Fischer G, Schneider C, Lenzinger E, Pezawas L, Schindler S, Eder H. Out-patient opiate detoxification treatment with buprenorphine. European Addictions Research 1998; 4: 198–202
   PubMed Web of Science ®Google Scholar
• Gibson A, Doran C, Bell J, Ryan A, Lintzeris N. A comparison of buprenorphine treatment in clinic and primary care settings: A randomized trial. The Medical Journal of Australia 2003; 170: 38–42
   Web of Science ®Google Scholar
• Ling W, Amass L, Shoptaw S, Annon J J, Hillhouse M, Babcock D, Brigham G, Harrer J, Reid M, Muir J, Buchan B, Orr D, Woody G, Krejci J, Ziedonis D. The Buprenorphine Study Protocol Group. A multi-center randomized trial of buprenorphone-naloxone versus clonidine for opioid detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction 2005; 100: 1090–1100
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Bell J, Bammer G, Jolley D J, Rushworth L. A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal. Addiction 2002; 97: 1395–1404
   PubMed Web of Science ®Google Scholar
• Seifert J, Metzner C, Paetzold W, Morsutzky M, Passie T, Rollnick J, Wises B, Emrich H M, Schneider U. Detoxification of opiate addicts with multiple drug abuse: A comparison of buprenorphine vs. methadone. Pharmacopsychiatry 2002; 35: 159–164
   PubMed Web of Science ®Google Scholar
• Vignau J. Preliminary assessment of a 10-day rapid detoxification program using high dosage buprenorphine. European Addiction Research 1998; 1(Suppl. 4)29–31
   Web of Science ®Google Scholar
• Digusto E, Lintzeris N, Breen C, Kimber J, Mattick R, Bell J, Ali R, Saunders J B. Short-term outcomes of five heroin detoxification methods in the Australian NEPOD project. Addictive Behaviors 2005; 30: 443–456
   PubMed Web of Science ®Google Scholar
• Marsch L A, Bickel W K, Badger G J, Stothart M E, Quesnel K J, Stanger C, Brooklyn J. Comparison of pharmacological treatments for opioid-dependent adolescents: A randomized controlled trial. Archives of General Psychiatry 2005; 62: 1157–1164
   PubMed Web of Science ®Google Scholar
• Broers B, Giner F, Damont P, Mino A. Impatient opiate detoxification in Geneva: Following-up at 1 and 6 months. Drug and Alcohol Dependence 2000; 58: 85–92
   PubMed Web of Science ®Google Scholar
• Chutuape M, Jasinski D, Fingerhood M, Stitzer M. One-, three-, and six-month outcomes after brief inpatient opioid detoxification. American Journal of Drug and Alcohol Abuse 2001; 27: 19–44
   PubMed Web of Science ®Google Scholar
• Hattenschwiler J, Ruesch P, Hell D. Effectiveness of inpatient drug detoxification: Links between process and outcome variables. European Addiction Research 2000; 6: 123–131
   PubMed Web of Science ®Google Scholar
• Wesson D. Buprenorphine in the treatment of opiate dependence: Its pharmacology and social context of use in the U.S. Psychoactive Drugs 1995; 2: 119–128
   Google Scholar
• Chutuape M, Katz E, Stitzer M. Methods for enhancing transition of substance dependent patients from inpatient to outpatient treatment. Drug and Alcohol Dependence 2001; 61(2)137–143
   PubMed Web of Science ®Google Scholar
• Mark T, Dilonardo J, Chalk M, Coffey R. Substance Abuse Detoxification: Improvements Needed in Linkage to Treatment. Substance Abuse and Mental Health Service Administration, Rockville, MD 2002, Report no. (SMA) 02-3728
   Google Scholar
• Mark T, Dilonardo J, Chalk M, Coffey R. Factors associated with the receipt of treatment following detoxification. Journal of Substance Abuse Treatment 2003; 24(4)299–304
   PubMed Web of Science ®Google Scholar
• Katz E C, Brown B S, Schwartz R, Weintraub E, Barksdale W, Robinson R. Role induction: A strategy for improving retention in outpatient drug-free treatment. Journal of Consulting and Clinical Psychology 2004; 72: 227–234
   PubMed Web of Science ®Google Scholar
• McLellan A T, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 1992; 9: 199–213
   PubMed Web of Science ®Google Scholar
• Bickel W, Amass L, Higgins S, Badger G, Esch R. Effects of adding behavioral treatment to opioid detoxification with buprenorphine. Journal of Consulting and Clinical Psychology 1997; 65: 803–810
   PubMed Web of Science ®Google Scholar
• Amass L, Ling W, Freese T E, Reiber C, Annon J J, Cohen A J, McCarty D, Reid M S, Brown L S, Clark C, Ziedonis D A, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir J A, Buchan B J, Horton T. Bringing buprenorphine-naloxone detoxification to community treatment providers: The NIDA Clinical Trials Network field experience. The American Journal of Addictions 2004; 13: S42–S66
   PubMed Web of Science ®Google Scholar
• Amass L, Winhusen T, Harrer J M, Pelt A. Using buprenorphine short-term taper to facilitate early treatment engagement. Journal of Substance Abuse Treatment 2007; 32: 349–356
   PubMed Web of Science ®Google Scholar